Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Mechanisms Underlying Augmented Lymphomagenesis by LUBAC; Possible Accumulation of AID-Mediated Somatic Mutations

Tomoyasu Jo, MD, Momoko Nishikori, MD PhD, Yoshiteru Sasaki, MD PhD, Yasunori Kogure, MD PhD, Keisuke Kataoka, MD PhD, Seishi Ogawa, MD PhD, Kazuhiro Iwai, MD PhD, Akifumi Takaori-Kondo, MD PhD

Blood (2018) 132 (Supplement 1): 775.

https://doi.org/10.1182/blood-2018-99-111097

Published: 2018

Journal Articles

Hyperactivable NFAT1 Ameliorates Autoimmune Encephalitis In Vivo.

Srimoyee Ghosh, PhD, Sergei B Koralov, PhD, Irena Stevanovic, MD, Mark S Sundrud, PhD, Yoshiteru Sasaki, MD, PhD, Klaus Rajewsky, MD, Anjana Rao, PhD, Martin R Mueller, MD, PhD

Blood (2009) 114 (22): 711.

https://doi.org/10.1182/blood.V114.22.711.711

Published: 2009

Journal Articles

Generation of vFLIP Transgenic Mice: A Model to Study KSHV-Associated Lymphomagenesis

Gianna Ballon, MD, Amy Chadburn, MD, Rocio Perez, MA, Yi-Fang Liu, MD, Yoshiteru Sasaki, MD, PhD, Ethel Cesarman, MD, PhD

Blood (2008) 112 (11): 81.

https://doi.org/10.1182/blood.V112.11.81.81

Published: 2008

Journal Articles

Evidence for NFAT1 as a Tumor Suppressor in T-ALL

Martin R Mueller, MD, PhD, Bruno K Robbs, PhD, Andre LS Cruz, PhD, Yoshiteru Sasaki, MD, PhD, Irena Stevanovic, Klaus Rajewsky, MD, Joao PB Viola, PhD, Anjana Rao, PhD

Blood (2008) 112 (11): 3804.

https://doi.org/10.1182/blood.V112.11.3804.3804

Published: 2008

Journal Articles

Expression of Hyperactivable NFAT1 from the ROSA26 Locus Leads to Detrimental Effects during Embryonic Development.

Martin R. Mueller, MD, PhD, Yoshiteru Sasaki, MD, PhD, Sonia Sharma, PhD, Srimoyee Ghosh, PhD, Curtis Gelinas, Edward L. Lamperti, PhD, Klaus Rajewsky, MD, Anjana Rao, PhD

Blood (2007) 110 (11): 2296.

https://doi.org/10.1182/blood.V110.11.2296.2296

Published: 2007

Journal Articles

The Role of the Transcription Factor NFAT in the Pathogenesis of Non-Hodgkin’s Lymphomas.

Martin R. Mueller, MD, PhD, Yoshiteru Sasaki, MD, PhD, Sonia Sharma, PhD, Klaus Rajewsky, MD, Anjana Rao, PhD

Blood (2006) 108 (11): 2371.

https://doi.org/10.1182/blood.V108.11.2371.2371

Published: 2006

NARROW

Mechanisms Underlying Augmented Lymphomagenesis by LUBAC; Possible Accumulation of AID-Mediated Somatic Mutations

Hyperactivable NFAT1 Ameliorates Autoimmune Encephalitis In Vivo.

Generation of vFLIP Transgenic Mice: A Model to Study KSHV-Associated Lymphomagenesis

Evidence for NFAT1 as a Tumor Suppressor in T-ALL

Expression of Hyperactivable NFAT1 from the ROSA26 Locus Leads to Detrimental Effects during Embryonic Development.

The Role of the Transcription Factor NFAT in the Pathogenesis of Non-Hodgkin’s Lymphomas.

Email alerts

ASH Publications

American Society of Hematology

Mechanisms Underlying Augmented Lymphomagenesis by LUBAC; Possible Accumulation of AID-Mediated Somatic Mutations

Hyperactivable NFAT1 Ameliorates Autoimmune Encephalitis In Vivo.

Generation of vFLIP Transgenic Mice: A Model to Study KSHV-Associated Lymphomagenesis

Evidence for NFAT1 as a Tumor Suppressor in T-ALL

Expression of Hyperactivable NFAT1 from the ROSA26 Locus Leads to Detrimental Effects during Embryonic Development.

The Role of the Transcription Factor NFAT in the Pathogenesis of Non-Hodgkin’s Lymphomas.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only